ArticleJournal of surgical case reports2026
Adenoid cystic carcinoma of the trachea: an uncommon presentation of a rare malignancy.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenoid cystic carcinoma (ACC) is a rare salivary gland tumor characterized by an indolent yet aggressive course, facilitated by perineural invasion, a propensity for delayed distant metastases, and recurrence after resection. A 61-year-old female presented with a three-month history of intermittent hoarseness and resting dysphagia. Contrast-enhanced computed tomography demonstrated a subglottic mass with proximal tracheal invasion, and ultrasound-guided neck fine-needle aspiration cytology was consistent with ACC. Surgical management included total laryngectomy with proximal tracheal and left thyroid lobe resection, followed by immediate tracheostomy. ACC was confirmed on histopathology with negative margins, and adjuvant radiotherapy (RT) was initiated to reduce locoregional recurrence risk. At one-year follow-up, the patient remains in remission with no evidence of recurrence or metastasis. Early symptom recognition and surgery with adjuvant radiotherapy remain central to local disease control, and long-term surveillance is essential given the potential for late recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.